Science fiction has probably done a huge disservice to the emerging bioeconomy, depicting any engagement with biology-based entities or systems with what always seems to include the prerequisite …
The Interim Report of the U.S. National Security Commission on Emerging Biotechnology
The U.S. National Security Commission on Emerging Biotechnology publicly released its first report in January of this year - with ideas and recommendations "they will be advancing throughout …
DoD launches the OTA-Funded Distributed Bioindustrial Manufacturing Investment Program: Seeks Industry Proposals
For the seasoned government contractor and acquisitions professional, the not very tightly held secret is the Other Transaction Agreement (OTA) is the only formal mechanism currently available for the …
Recent Developments in and the Future of the Bioeconomy in 2024
We have tracked vital recent developments in health security, bioengineering, synthetic biology, biotechnology, and medical technology - which are compiled here. The future of the U.S. Bioeconomy is …
Continue Reading about Recent Developments in and the Future of the Bioeconomy in 2024
The First FDA Approved CRISPR-based Medicine and the First Programmable, Logical Quantum Processor
The next ten years will be marked by all the uncertainties and unintended consequences that underpin so many doom and gloom scenarios. It is time to start tracking the abundance and breakthroughs …
The Future Now: The State of the Bioeconomy in 2023
The future is now. The Bioeconomy in 2023 is showing clear signs of opportunities for advantage created by the exponential disruption of the industrial base (including that of defense), coupled with …
Continue Reading about The Future Now: The State of the Bioeconomy in 2023
The Strategic Implications of the Recent Data Scraping of Genetic Testing Market Leader 23andMe
The exponential growth of the bioeconomy is all at once an opportunity for strategic competitive advantage and wrought with the perils of unintended consequences wrought by broad data security and …
The YouBase Case Study: Managing Genetic and Health Data on the Blockchain
Opportunities for advantage will be created by the exponential disruption of the industrial base (including that of defense) coupled with exponential biotechnology innovation to build the bioeconomy …
Continue Reading about The YouBase Case Study: Managing Genetic and Health Data on the Blockchain
Blockchain Meets Bio: The Recent Synthetic Biology Summit and “Sustainable Biomanufacturing for Future Network States”
Opportunities for advantage will be created by the exponential disruption of the industrial base (including that of defense) coupled with exponential biotechnology innovation to build the bioeconomy …